Litcius/Paper detail

Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats

Qian Li, Fang Yuan, Dewei Peng, Lu-an Li, Chunyu Deng, Hui Yang, Su‐Juan Kuang, Qiaoqiao Li, Mengzhen Zhang, Peng Zeng, Qianhuan Zhang, Yang Liu, Hai Deng, Wei Wei, Yumei Xue, Shulin Wu, Fang Rao

2023European Journal of Pharmacology22 citationsDOI

Topics & Concepts

ValsartanAtrial fibrillationInternal medicineAngiotensin receptorSacubitrilNeprilysinAngiotensin II receptor type 1Angiotensin IIEndocrinologySacubitril, ValsartanMedicineHeart failureCardiologyChemistryReceptorBlood pressureEnzymeBiochemistryAtrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmiasHeart Failure Treatment and Management
Sacubitril/valsartan reduces susceptibility to atrial fibrillation by improving atrial remodeling in spontaneously hypertensive rats | Litcius